592 related articles for article (PubMed ID: 31846838)
1. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.
Kopecka J; Trouillas P; Gašparović AČ; Gazzano E; Assaraf YG; Riganti C
Drug Resist Updat; 2020 Mar; 49():100670. PubMed ID: 31846838
[TBL] [Abstract][Full Text] [Related]
2. What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg.
Alexa-Stratulat T; Pešić M; Gašparović AČ; Trougakos IP; Riganti C
Drug Resist Updat; 2019 Sep; 46():100643. PubMed ID: 31493711
[TBL] [Abstract][Full Text] [Related]
3. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
4. Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition.
Gelsomino G; Corsetto PA; Campia I; Montorfano G; Kopecka J; Castella B; Gazzano E; Ghigo D; Rizzo AM; Riganti C
Mol Cancer; 2013 Nov; 12():137. PubMed ID: 24225025
[TBL] [Abstract][Full Text] [Related]
5. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
Mohammad IS; He W; Yin L
Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
[TBL] [Abstract][Full Text] [Related]
6. Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition.
Yun UJ; Lee JH; Koo KH; Ye SK; Kim SY; Lee CH; Kim YN
Biochem Pharmacol; 2013 May; 85(10):1441-53. PubMed ID: 23473805
[TBL] [Abstract][Full Text] [Related]
7. Molecular Modeling Strategies of Cancer Multidrug Resistance.
Yalcin-Ozkat G
Drug Resist Updat; 2021 Dec; 59():100789. PubMed ID: 34973929
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains.
Hinrichs JW; Klappe K; van Riezen M; Kok JW
J Lipid Res; 2005 Nov; 46(11):2367-76. PubMed ID: 16150833
[TBL] [Abstract][Full Text] [Related]
9. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
[TBL] [Abstract][Full Text] [Related]
11. Lipids as a target for drugs modulating multidrug resistance of cancer cells.
Hendrich AB; Michalak K
Curr Drug Targets; 2003 Jan; 4(1):23-30. PubMed ID: 12528987
[TBL] [Abstract][Full Text] [Related]
12. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells.
Palko-Łabuz A; Środa-Pomianek K; Wesołowska O; Kostrzewa-Susłow E; Uryga A; Michalak K
Biomed Pharmacother; 2019 Jan; 109():1511-1522. PubMed ID: 30551403
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.
Pérez-Tomás R
Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198
[TBL] [Abstract][Full Text] [Related]
14. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
15. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy.
Liu D; Rong H; Chen Y; Wang Q; Qian S; Ji Y; Yao W; Yin J; Gao X
Br J Pharmacol; 2022 Jul; 179(13):3346-3362. PubMed ID: 35040123
[TBL] [Abstract][Full Text] [Related]
17. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR).
Lee CH
Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411
[TBL] [Abstract][Full Text] [Related]
18. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
20. Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma.
Besse L; Besse A; Stolze SC; Sobh A; Zaal EA; van der Ham AJ; Ruiz M; Phuyal S; Büchler L; Sathianathan M; Florea BI; Borén J; Ståhlman M; Huber J; Bolomsky A; Ludwig H; Hannich JT; Loguinov A; Everts B; Berkers CR; Pilon M; Farhan H; Vulpe CD; Overkleeft HS; Driessen C
Cancer Res; 2021 Sep; 81(17):4581-4593. PubMed ID: 34158378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
